XM does not provide services to residents of the United States of America.
P
P

Philips


News

Philips And AWS Collaborate To Scale Digital Pathology In Cloud

BRIEF-Philips And AWS Collaborate To Scale Digital Pathology In Cloud March 12 (Reuters) - Koninklijke Philips NV PHG.AS : PHILIPS AND AWS AMZN.O COLLABORATE TO SCALE DIGITAL PATHOLOGY IN THE CLOUD, ENHANCING DIAGNOSTIC CAPABILITIES AND IMPROVING PRODUCTIVITY CLOUD OFFERING WILL HELP IMPROVE WORKFLOW INTEGRATION, ACCESS, AND RELIABILITY, DELIVERING
A
P

Exor takes 10% stake in data provider Clarivate, can rise to 17.5%

UPDATE 1-Exor takes 10% stake in data provider Clarivate, can rise to 17.5% Adds background in paragraphs 2 and 5-8 MILAN, March 4 (Reuters) - Italy's Agnelli family has a 10.1% stake in New York-listed information services provider Clarivate 16A.F through their investment arm Exor EXOR.AS , the two companies said on Monday, adding that Exor could increase its stake to up to 17.5%.
F
P
J

Philips Appoints Charlotte Hanneman As New CFO

BRIEF-Philips Appoints Charlotte Hanneman As New CFO Feb 28 (Reuters) - Koninklijke Philips NV PHG.AS : CHARLOTTE HANNEMAN TO SUCCEED ABHIJIT BHATTACHARYA AS PHILIPS’ CHIEF FINANCIAL OFFICER (CFO) APPOINT CHARLOTTE HANNEMAN AS MEMBER OF BOARD OF MANAGEMENT, FULFILLING ROLE OF CHIEF FINANCIAL OFFICER (CFO), EFFECTIVE OCTOBER 1, 2024 PROPOSAL WILL
P

Philips Launches New Azurion Neuro Biplane System

BRIEF-Philips Launches New Azurion Neuro Biplane System Feb 27 (Reuters) - Koninklijke Philips NV PHG.AS : PHILIPS LAUNCHES NEW AZURION NEURO BIPLANE SYSTEM AT #ECR2024 TO SPEED UP AND IMPROVE MINIMALLY INVASIVE DIAGNOSIS AND TREATMENT OF NEUROVASCULAR PATIENTS Source text for Eikon: ID:nGNX9CrS9c Further company coverage: PHG.AS
P

Rotech says patients likely impacted by hack at partner Philips' unit

UPDATE 1-Rotech says patients likely impacted by hack at partner Philips' unit Adds Philips' emailed response in paragraph 5 Feb 23 (Reuters) - U.S.-based medical devices provider Rotech Healthcare ROTK.O said on Friday it was reviewing a list of patients who may have been impacted due to a cybersecurity breach experienced by its partner Philips' PHG.AS Respironics unit.
P

Rotech says third-party hacked partner Philips Respironics

CORRECTED-Rotech says third-party hacked partner Philips Respironics Corrects date in paragraph 2 to June 5 from June 23 Feb 23 (Reuters) - Rotech Healthcare said on Friday it was reviewing a list of patients who may have been impacted due to a cybersecurity breach experienced by its partner Philips' PHG.AS Respironics unit. On June 5 last year, the unit, which sells breathing devices and ventilators to treat sleep apnea, was made aware of a privacy incident where an unauthorized third-party exp
P

Soccer-De Jong penalty earns PSV draw with Dortmund in Champions League last-16

UPDATE 2-Soccer-De Jong penalty earns PSV draw with Dortmund in Champions League last-16 adds quotes EINDHOVEN, Netherlands, Feb 20 (Reuters) - Donyell Malen scored a superb goal against his former side but a second-half penalty from Luuk de Jong earned a 1-1 draw for PSV Eindhoven in the first leg of their Champions League last-16 tie against Borussia Dortmund at the Philips Stadion on Tuesday.
P

Soccer-PSV held by Dortmund in Champions League last-16

Soccer-PSV held by Dortmund in Champions League last-16 EINDHOVEN, Netherlands, Feb 20 (Reuters) - Donyell Malen scored a superb goal against his former side but a second-half penalty from Luuk de Jong earned a 1-1 draw for PSV Eindhoven in the first leg of their Champions League last-16 tie against Borussia Dortmund at the Philips Stadion on Tuesday.
P

US Supreme Court won't review Apple's win against $503 million patent verdict

US Supreme Court won't review Apple's win against $503 million patent verdict By Blake Brittain WASHINGTON, Feb 20 (Reuters) - The U.S. Supreme Court on Tuesday declined to hear patent-licensing company VirnetX's VHC.N bid to revive a $502.8 million jury verdict it won against Apple AAPL.O in a dispute over internet-security patents. The justices turned away Zephyr Cove, Nevada-based VirnetX's appeal of a lower court's decision to overturn the verdict against Cupertino, California-based Apple th
A
P

Philips Nominates Benoît Ribadeau-Dumas As Member Of Supervisory Board In Line With Exor's Proposal

BRIEF-Philips Nominates Benoît Ribadeau-Dumas As Member Of Supervisory Board In Line With Exor's Proposal Feb 20 (Reuters) - Koninklijke Philips Nv PHG.AS : PHILIPS PROPOSES TO RE-APPOINT CHAIRMAN FEIKE SIJBESMA AND PETER LÖSCHER AND NOMINATES BENOÎT RIBADEAU-DUMAS AS MEMBER OF THE SUPERVISORY BOARD IN ACCORDANCE WITH THE PROPOSAL THAT EXOR HAS MADE, SUPERVISORY BOARD NOW PROPOSES TO APPOINT MR.
P

Philips Respond To FDA Recall Of Imaging Machines

BRIEF-Philips Respond To FDA Recall Of Imaging Machines Feb 15 (Reuters) - PHILIPS- PHILIPS IN RESPONSE TO FDA RECALL OF IMAGING MACHINES: FIELD SAFETY NOTICE IN DEC DUE TO COMPLAINT RECEIVED FROM POST MARKET SURVEILLANCE ACTIVITIES PHILIPS IN RESPONSE TO FDA RECALL OF IMAGING MACHINES: FINANCIAL/COMMERCIAL IMPACT OF FIELD SAFETY NOTICE IS NEGLIGIB
P

US FDA classifies Philips' recall of imaging machines as most serious

UPDATE 3-US FDA classifies Philips' recall of imaging machines as most serious Adds company's response in paragraphs 6 and 8 Feb 15 (Reuters) - The U.S. FDA said on Thursday it has classified a recall of Philips' PHG.AS medical imaging machines as most serious due to the risk of a detector in some devices unexpectedly falling on patients during scans.
P

US FDA classifies Philips' recall of imaging machines as 'most serious'

US FDA classifies Philips' recall of imaging machines as 'most serious' Feb 15 (Reuters) - The U.S. FDA said on Thursday it has classified a recall of Philips' PHG.AS medical imaging machines as "most serious" due to the risk of a detector falling unexpectedly in some devices. Philips' recall of BrightView Imaging Systems, used for single photon emission computed tomography (SPECT) scan, is to correct the faulty component, the health regulator said.
P

Morphosys, Renishaw, Verallia

EUROPE RESEARCH ROUNDUP-Morphosys, Renishaw, Verallia Feb 7 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including Morphosys, Renishaw and Verallia, on Wednesday. HIGHLIGHTS * Biopharma Credit Plc BPCR.L : Jefferies cuts to hold from buy * Morphosys AG MORG.DE : Citigroup raises to neutral from sell * Nordic Semiconductor ASA NOD.OL : Jefferies cuts to hold from buy * Renishaw Plc RSW.L : Stifel cuts to hold from buy * Verallia SA VRLA.PA
A
A
A
B
C
D
F
H
H
H
I
M
P
R
S
U
U
V
A
A
I
J

Cellnex Telecom, KPN, Puma

EUROPE RESEARCH ROUNDUP-Cellnex Telecom, KPN, Puma Feb 1 (Reuters) - Securities analysts revised their ratings and price targets on several European companies including Cellnex Telecom, KPN and Puma, on Thursday. HIGHLIGHTS * Big Yellow Group Plc BYG.L : Goldman Sachs adds stock to its european conviction list * Cellnex Telecom SA CLNX.MC : Goldman Sachs adds stock to its european conviction list * KPN KPN.AS : Citigroup raises to buy from neutral * MTU Aero Engines MTXGn.DE : Citigroup cuts to
A
B
C
C
D
E
E
E
G
K
P
P
R
A
H
E
N

US FDA says 561 deaths related to Philips machines since 2021

UPDATE 2-US FDA says 561 deaths related to Philips machines since 2021 Adds company's response in paragraphs 3 and 5 Jan 31 (Reuters) - The U.S. Food and Drug Administration said on Wednesday there have been 561 deaths reported since 2021 related to the use of Philips' PHG.AS recalled ventilators and machines for treating obstructive sleep apnea. The health regulator added that in 2023, between July and September, it received more than 7,000 medical device reports, including 111 reports of death
P

US FDA says reported deaths from Philips machines reach 561

US FDA says reported deaths from Philips machines reach 561 Jan 31 (Reuters) - The U.S. Food and Drug Administration said on Wednesday there have been 561 deaths reported since 2021 related to the use of Philips' PHG.AS recalled ventilators and machines for treating obstructive sleep apnea. Reporting by Christy Santhosh; Editing by Krishna Chandra
P

FDA says received more than 7,000 medical device reports, 111 death reports From July 1, 2023 – Sept 30, 2023

BRIEF-FDA says received more than 7,000 medical device reports, 111 death reports From July 1, 2023 – Sept 30, 2023 Jan 31 (Reuters) - Koninklijke Philips NV PHG.AS : FDA:FROM JULY 1- SEPT 30,2023,GOT OVER 7,000 REPORTS ON PHILIPS RESPIRONICS VENTILATORS,BIPAP,CPAP MACHINES RECALL OF JUNE 2021 WITH 111 DEATH REPORTS FDA:SINCE APRIL 2021, GOT OVER
P

Antofagasta, Rational, Spirax-Sarco

EUROPE RESEARCH ROUNDUP-Antofagasta, Rational, Spirax-Sarco Jan 31 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including Antofagasta, Rational and Spirax-Sarco, on Wednesday. HIGHLIGHTS * Antofagasta ANTO.L : Citigroup raises target price to 2100p from 1700p * Deutsche Bank AG DBKGn.DE : Citigroup cuts to neutral from buy * Rational AG RAAG.DE : Exane BNP Paribas cuts to underperform from neutral * Spirax-Sarco SPX.L : Jefferies raises t
3
A
A
A
A
A
A
B
C
C
D
D
D
D
D
D
D
E
E
E
G
H
H
H
I
K
L
L
P
P
R
R
S
S
S
S
U
V
W
A
A
B
E
F
S
Z

New York Times business news - Jan 30

PRESS DIGEST-New York Times business news - Jan 30 Jan 30 (Reuters) - The following are the top stories on the New York Times business pages. Reuters has not verified these stories and does not vouch for their accuracy. - Neuralink, a company working to develop computer interfaces that can be implanted in human brains, placed its first device in a patient on Sunday, said founder Elon Musk.
A
P



Conditions

Popular Assets

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.